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Abstract
Background: Ascitic fluid infection (AFI) in cirrhotic patients has a high morbidity and mortality.
It has two variants namely, spontaneous bacterial peritonitis (SBP) and culture negative neutrocytic
ascites (CNNA). The aim of this study was to determine the outcome in cirrhotic patients with
culture positive (SBP) and culture negative neutrocytic ascites.
Methods: We analyzed 675 consecutive hepatitis B and/or C related cirrhosis patients with ascites
admitted in our hospital from November 2005 to December 2007. Of these, 187 patients had AFI;
clinical and laboratory parameters of these patients including causes of cirrhosis, Child Turcotte
Pugh (CTP) score were recorded.
Results: Out of 187 patients with AFI, 44 (23.5%) had SBP while 143 (76.4%) had CNNA. Hepatitis
C virus (HCV) infection was the most common cause of cirrhosis in 139 (74.3%) patients. Patients
with SBP had high CTP score as compared to CNNA (12.52 ± 1.45 vs. 11.44 ± 1.66); p < 0.001.
Platelets count was low in patients with SBP (101 ± 53 × 109/L) as compared to CNNA (132 ± 91
× 109/L), p = 0.005. We found a high creatinine (mg/dl) (1.95 ± 1.0 vs. 1.44 ± 0.85), (p = 0.003) and
high prothrombin time (PT) in seconds (24.8 ± 6.6 vs. 22.4 ± 7.2) (p = 0.04) in SBP as compared to
CNNA. More patients with SBP (14/44; 31.8%) had blood culture positivity as compare to CNNA
(14/143; 9.8%), p = 0.002. Escherichia. Coli was the commonest organism in blood culture in 15/28
(53.5%) patients. SBP group had a higher mortality (11/44; 25%) as compared to CNNA (12/143;
8.4%), p = 0.003. On multiple logistic regression analysis, creatinine >1.1 mg/dl and positive blood
culture were the independent predictors of mortality in patients with SBP.
Conclusion: Patients with SBP have a higher mortality than CNNA. Independent predictors of
mortality in SBP are raised serum creatinine and a positive blood culture.
Background
Ascitic fluid infections (AFI) are frequent and severe com-
plication in cirrhotic patients and have a high morbidity
and mortality. Two variants of AFI have been described in
medical literature, 1) Spontaneous bacterial peritonitis
(SBP) with polymorph nuclear (PMN) count >250/mm3
and positive ascitic fluid culture without any evidence of
external or intra-abdominal source of infection [1] and 2)
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Culture negative neutrocytic ascites (CNNA) with PMN >
250/mm3 and a negative ascitic fluid culture [2].
The first description of SBP did not include those patients
who had a negative ascitic fluid culture. The term CNNA
was proposed in 1984 [2] and is considered a variant of
SBP associated with lower mortality as compared to SBP
[3]. Then it was decided that an ascitic fluid PMN count
>250/mm3 in the absence of evidence of abdominal infec-
tion is also a form of AFI even though the ascitic culture is
negative [4].
SBP is a serious complication of end-stage liver disease,
with a very high recurrence rate of up to 70% at 1 yr [5-7],
and is seen in 8–27% of hospitalized patients with cirrho-
sis and ascites. Studies suggest that the in-hospital mortal-
ity in patients with SBP ranges from 20% to 40% [8,9].
There are few studies addressing the outcome in cirrhotic
patients with AFI [3,4,9]. One of the studies found high
creatinine and blood urea nitrogen (BUN) on admission
to be associated with high mortality regardless of ascitic
fluid culture positivity and type of organism [9].
There is a paucity of literature comparing the outcome in
patients based on culture results, and factors predicting
poor prognosis in cirrhotic patients with ascitic fluid
infection. The available literature has included very lim-
ited number of patients with the two variants AFI and
shows low mortality in CNNA as compared to SBP [3].
Moreover, majority of these studies are reported in
patients with alcoholic cirrhosis [4].
We studied the outcome in the two variants of AFI in a
large cohort of patients with viral causes of cirrhosis
including hepatitis B and/or hepatitis C in a tertiary care
University Hospital setting.
Methods
We analyzed 675 consecutive patients with viral causes of
cirrhosis along with ascites admitted at The Aga Khan Uni-
versity Hospital from November 2005 to December 2007.
The medical records of patients admitted with symptoms
and signs of ascitic fluid infection such as fever, abdomi-
nal pain and those with asymptomatic infection were
retrieved. The data of their age, gender, clinical features,
complications such as hepatic encephalopathy, upper GI
bleed, hepatocellular carcinoma, etc was collected along
with laboratory data and the Child Turcotte Pugh (CTP)
score was calculated for all patients. All patients had liver
cirrhosis diagnosed on clinical, hematological and bio-
chemical laboratory parameters along with ultrasonologi-
cal findings. 187 patients with ascitic fluid infections met
the criteria in the form of either SBP or CNNA and they
were included in the study. Only patients who had first
episode of either SBP or CNNA were included in this
study. Patients with secondary bacterial peritonitis, non-
cirrhotics causes of ascites such as tuberculosis or malig-
nancy were excluded. Those with cirrhosis and ascites who
received systemic antibiotics within 30 days for any other
infection (s) were also excluded from the study. Patients
with cirrhosis due to causes other than hepatitis B, C or D
viral infections were also excluded.
Diagnostic paracentesis was performed on the bed side by
sterile method with a 21 G needle attached to 20 cc
syringe, and then collected into Ethylene Diamine Tetra
Acetate (EDTA) tube and analyzed within 3 hours of
extraction. Ascitic fluid was then centrifuged in laboratory
for 3 minutes for detailed report including total proteins,
total and differential leukocyte count. Smear was per-
formed and stained with Geimsa. At the same time 10 cc
of ascitic fluid (5 cc in each bottle) was inoculated in aer-
obic and anaerobic blood culture bottles (Bactec 9240,
Becton Dickinson, Ireland) containing Trypticase foy
broth and processed according to manufacture's instruc-
tions and were observed for 1 month.
Similarly, blood cultures were also drawn in aerobic and
anaerobic blood culture bottles, before starting antibiot-
ics. All patients were treated with ceftriaxone 2 grams once
daily and it was changed to appropriate antibiotic (s)
based on less than 50% improvement in PMN count in
the repeat ascitic fluid detailed report after 48 hours or
culture sensitivity results of initial ascitic fluid. Recovery
from the AFI was assessed on the basis of decrease in
ascitic fluid PMN count to < 250/mm3.
This study is approved by the Ethics Review Committee
(ERC) of Aga Khan University Hospital.
Statistical Analysis
Statistical analysis was performed using the Statistical
package for social science SPSS (Release 15.0, standard
version, copyright© SPSS; 1989–02). A descriptive analysis
was performed for clinical features and results are pre-
sented as mean ± standard deviation for quantitative var-
iables and numbers (percentages) for qualitative
variables. χ2 test and Fisher's exact test were used for cate-
gorical variables, while the independent sample t-test was
applied for numerical variables. We used a one-way anal-
ysis of variance (ANOVA) for determining any statistical
difference amongst the subgroups. Variables found to be
statistically significant in the univariate analysis (p ≤ 0.25)
were included in a multivariate stepwise logistic regres-
sion model. The model was constructed to identify inde-
pendent predictors of mortality in patients with SBP and
to obtain the odds ratio.
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All p-values were two sided and considered as statistically
significant if < 0.05.
Results
A total of 675 patients were admitted with ascites due to
cirrhosis during the study period. Of these 187 (27.7%)
patients with AFI were included for analysis. There were
44 (23.5%) patients who had SBP while 143 (76.4%) had
CNNA (Figure 1).
The demographics and clinical data of patients with SBP
and CNNA patients are shown in Table 1. The two groups
of AFI patients, i.e., SBP and CNNA were matched for age,
gender, clinical features, and complications such as upper
GI bleed and hepatoma. The patients with SBP had statis-
tically significant incidence of hepatic encephalopathy 36
(81.8%) vs. 83 (58%), p-value = 0.004; and had advanced
CTP score 12.52 ± 1.45 at the time of admission as com-
pared to CNNA group, 11.44 ± 1.66, p-value = <0.001.
Majority of hematological and biochemical laboratory
tests including hemoglobin, white blood cells (WBC)
counts, and liver function tests were similar in the two
groups. There were significantly low levels of platelets in
SBP group (101 ± 53 × 109/L) as compared to CNNA (132
± 91 × 109/L), p-value = 0.005; similarly, SBP group had a
high creatinine level (1.95 ± 1.0 mg/dl) as compared to
CNNA (1.44 ± 0.85 mg/dl), p-value = 0.003. Ascitic fluid
WBC counts were not different in the two groups, while
blood cultures were significantly positive in patients with
SBP. Table 2.
Hepatitis C virus (HCV) infection was the most common
underlying cause of cirrhosis in 139 (74.3%) followed by
hepatitis B virus (HBV) infection in 43 (22.9%); out of
these 43 patients 12 (6.4%) had concomitant hepatitis D
virus infection. Moreover, 5 (2.6%) patients had concom-
itant HBV and HCV infection causing cirrhosis.
Out of 187 patients with AFI, 44 (23.5%) had culture pos-
itive ascitic fluid cultures i.e., SBP; of these 32 (72.7%)
patients had gram negative bacterial infection, while rest
of 12 (27.2%) had gram positive infection. Escherichia.
Coli (E. Coli) being the most common organism isolated
from 27 (61.3%) patients. Table 3 shows the other organ-
isms isolated from ascitic fluid cultures.
Overall 28/187 (14.9%) patients had positive blood cul-
ture results. The yield of culture was higher in SBP group
(14/44; 31.8%) as compared to CNNA group (14/143;
9.8%), p-value = 0.002. There were 17 (60.7%) gram neg-
ative and 11 (39.2%) gram positive bacterial infection.
Among the gram-negative organisms, E. coli was the most
common isolated from blood culture in 15/28 (53.5%)
patients.
All patients were started on intravenous ceftriaxone 2
grams once daily, after drawing ascitic and blood cultures.
Intravenous salt poor albumin (25%), 100 ml twice a day
for 5 days was given to all patients with a creatinine level
of >1.5 mg/dl as per the protocol of our Gastroenterology
Section. Out of 44 patients with SBP 13 were resistant to
first line antibiotic; 7/32 (22%) were resistant in gram
negative group while 6/12 (50%) in gram positive infec-
tion group. Gram negative resistant organisms were sensi-
tive to other beta-lactam antibiotics; five of these patients
were treated with piperacillin tazobactam and 2 received
imepenam (carbepenam group) as per treating physi-
cian's decision. Similarly, vancomycin was given in 6
patients in whom ascitic culture was positive for Staphylo-
coccus and Enterococcus species. Out of these 13 patients
with resistant organism 8 died due to delay in start of
appropriate antibiotics. There was 11/44 (25%) in-hospi-
tal deaths in SBP group of patients as compared to 12/143
(8.4%) in CNNA group, p-value = 0.003; the causes of
death in SBP group were AFI and sepsis in 8 patients and
PSE, hematemesis and seizures in 1 patient each. Whereas
in CNNA 6 patients died of AFI and sepsis and 2 patients
each in PSE, seizures and pneumonia
Survival curve of patients with SBP and CNNA group of
ascitic fluid infection is shown in Figure 2.
Predictors of mortality in patients with SBP variant of
ascitic fluid infection, on univariate analysis were, pres-
ence of PSE, raised creatinine, low platelets counts,
increased PT. Furthermore, blood culture positive results
were also significant on univariate analysis for mortality
in patients with SBP. We analyzed all these factors along
Showing the distribution of patients with Cirrhosis and ascitesFigure 1
Showing the distribution of patients with Cirrhosis 
and ascites.
Total 675 cirrhotic patients admitted with ascites 
483 excluded 
(455 patients had no AFI, 25 patients had more than 1 episode of SBP and 
8 patients had prior antibiotic therapy in last 30 days) 
187 patients included in the study 
SBP (n=44)   CNNA (n=143)
    23.5%         76.4% 
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with those of a p-value of <0.25 for finding the independ-
ent predictors of mortality by logistic regression tech-
nique. After multiple logistic regression analysis we found
that a creatinine of >1.1 mg/dl and positive blood culture
were the independent predictors of mortality in patients
with SBP. Table 4
Discussion
This is one of the largest reports of hepatitis B and C virus
related cirrhotic patients with ascitic fluid infection. The
incidence of AFI, including SBP and CNNA was found to
be around 28%. We found that mortality is higher in
patients with SBP 11/44 (25%) as compared to CNNA 12/
143 (8.4%) in our series. We also found that the inde-
pendent predictors of mortality in SBP were raised creati-
nine (> 1.1 mg/dl) along with blood culture positivity.
SBP and CNNA are both considered serious complica-
tions of advanced liver cirrhosis [10]. Reported incidence
of AFI infection in cirrhotics ranges from 8–30% and
mean in- hospital mortality is reported to reach 78% [1].
Incidence of AFI in our series was 28%, which is similar to
reported literature.
Runyon and Hoefs in 1984 [2] studied 32 patients with a
positive ascitic fluid culture and 17 patients with a nega-
tive ascitic fluid culture, with their mortalities being 70%
and 50% respectively. There was however, no statistical
difference noted. In another study, Pelletier et al in 1990
studied 15 patients with CNNA and 38 patients with SBP
and showed the mortality to be considerably higher in
patients with SBP [11]. In our study mortality rates were
noted to be higher in patients with SBP (25%) than in
CNNA (8.4%), possibly suggesting that CNNA is a less
severe variant of SBP, despite the fact that both groups
received similar intravenous third generation antibiotic
and albumin. Different theories have been suggested for
ascitic fluid infection severity. Impaired activity of the
reticulo-endothelial system, decreased serum and ascitic
complement levels, and a low ascitic protein level are
some of the mechanisms responsible for entrance of
enteral organisms into the ascitic fluid of patients with
SBP [1]. Another established theory is that portal hyper-
tension increases bacterial translocation to the lymphatic
system and portal vein. The potential mechanisms
responsible for this action are bacterial overgrowth due to
impaired gastrointestinal transit, impaired host defense or
Table 1: Demographics and clinical variables among patients with SBP and CNNA
Variables SBP (n = 44); ±/(%) CNNA (n = 143); ±/(%) p- value
Age (years) 52.18 ± 10.6 53.49 ± 12.6 0.49
Gender
Male 23(52.3) 76 (53.1)
Female 21(47.7) 67 (46.9) 0.9
Fever 38(86.4) 125 (87.4) 0.8
Abdominal Pain 27(61.4) 80(55.9) 0.6
Encephalopathy 36 (81.8) 83(58) 0.004
GI bleed 5 (11.36) 14 (9.7) 0.10
CTP Score 12.52 ± 1.45 11.44 ± 1.66 <0.001
Hepatoma 7 (15.9) 39 (27.3) 0.12
Table 2: Comparison of laboratory data of patents with SBP and CNNA
Variables SBP ± SD (n = 44) CNNA ± SD (n = 143) p- value
Hemoglobin (g/dl) 10.43 ± 1.5 10.21 ± 1.9 0.44
WBC (109/L) 10.9 ± 7.3 10.4 ± 5.6 0.69
Platelets (109/L) 101 ± 53 132 ± 91 0.005
Creatinine (mg/dl) 1.95 ± 1 1.44 ± 0.85 0.003
Total Bilirubin (mg/dl) 7.82 ± 6.1 6.68 ± 6.8 0.30
SGPT (IU/L) 49.29 ± 41.4 60.58 ± 58.3 0.18
Prothrombin Time(s) 24.8 ± 6.6 22.4 ± 7.2 0.04
INR 2.05 ± 0.55 2.05 ± 2.5 0.99
Serum albumin (g/dl) 1.99 ± 0.37 2.04 ± 0.4 0.47
Ascitic TLC (cells/mm3) 4774 ± 3642.45 4384 ± 3638.71 0.70
Ascitic PMN (cells/mm3) 4055 ± 2860 3875 ± 2245 0.59
Blood culture positive 14 (31.8%) 14 (9.8%) 0.002
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morphological and functional damage to the bowel
mucosa [12]. Lower mortality rates in patients with CNNA
could be explained by a better hepatic function in terms of
better CTP in patients with CNNA. We know that CTP
score reflects the severity of portal hypertension and this
could contribute to more bacterial translocation in
patients with SBP.
In our report the rate of ascitic fluid bacterial growth was
less (23%) as compared to other reports, where it ranges
from 50 to 71% [3,11]. Use of blood culture bottles and
the volume of the blood sample drawn affect the yield of
culture. Sending a syringe or tube of fluid to the labora-
tory for culture dramatically decreases the sensitivity of
the results since SBP is a low-colony-count monomicro-
bial infection similar to bacteremia [13]. Thus, culturing
ascitic fluid as if it were blood (with bedside inoculation
of ascitic fluid into blood culture bottles) has been shown
to increase the culture-positivity of the ascitic fluid of
patients with an ascitic fluid PMN count >250 cells/mm3
(in the absence of prior antibiotic treatment, pancreatitis,
tuberculous peritonitis, or malignancy-related ascites)
from about 50% to approximately 80% [13]. We were
unable to find any reason for this low yield accept that the
amount of ascitic fluid inoculated was 5 cc in each bottle
as compared to few studies where 10 cc was inoculated
[4,11].
E. coli was the most common organism found in two
thirds of patients with SBP, monomicrobial gram-nega-
tive organism was recovered in 32 (72.7%) patients and E.
coli representing more than two thirds, which is similar to
other studies [3] (Table 3). In our patients with SBP,
blood culture yield was higher as compared to CNNA and
it is comparable to other studies [4,11]. Interestingly, we
found that, the death in patients resistant to first line anti-
biotic was high emphasizing on the need for an early
detection method of organism for appropriate antibiotics
according to sensitivity. Currently with an improvement
in culture technique, time required for bacterial growth
and its detection is usually more than 24 hours [14]. Con-
sidering the prognostic significance of early appropriate
antibiotic treatment in patients with SBP [15], it would be
pertinent to find a method to shorten the time for bacte-
rial identification in clinical practice such as BacT/ALERT
and bacterial DNA by PCR. BacT/ALERT is an automated
microbial detection system, which is proven to be faster
than conventional blood culture bottles in patients with
bacteremia [16]. An earlier report of sensitivity of bacteria
in ascitic fluid can be helpful in starting appropriate anti-
biotics, which can decrease mortality. In our study, raised
serum creatinine and a positive blood culture were found
to be the independent predictors of prognosis in SBP
patients. Similarly Follo A et al reported renal impairment
to be the most sensitive predicator of in hospital mortality
in ascitic fluid infection [17].
Table 3: Distribution of different organisms in patients with SBP 
(n = 44)
Organisms cultured n (%)
E. Coli 27 (61.3)
Streptococcus Pneumoniae 5 (11.3)
Pseudomonas species 4 (9)
Staphylococcus species 3 (6.8)
Enterococcus species 3 (6.8)
Bacillus species 1 (2.2)
Group D Streptococcus 1 (2.2)
Survival of patients and culture positive (SBP) and culture negative (CNNA)Fi ure 2
Survival of patients and culture positive (SBP) and 
culture negative (CNNA).
Table 4: Univariate and Multiple logistic regression analysis of 
predictors of mortality in SBP.
Univariate Analysis:
Characteristics Odd Ratio 95% CI p
PSE 3.25 1.41 –7.49 0.006
Cr (>1.1 mg/dl) 3.65 1.29 – 10.29 0.01
Platelets (<91 × 109/L) 3.35 1.65 – 6.79 0.001
PT (>24 Secs) 2.18 0.92 – 5.13 0.005
Blood culture positivity 4.30 1.85 – 9.96 0.001
Multiple logistic regression analysis:
Cr (>1.1 mg/dl) 5.78 1.23 – 27.1 0.02
Blood culture positivity 7.8 2.15 – 28.2 0.002
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Over all 23/187 (12.2%) patients with AFI died in our
report; out of this majority, belonged to SBP group. The
possible explanation for worse prognosis in SBP group
could be advanced liver cirrhosis in this group as evi-
denced by CTP score and more renal impairment (Table 1
and 2). There is literature to support that renal impair-
ment is a well-known prognostic factor of poor survival in
patients with SBP [17]. Several authors suggested that
CNNA and SBP are two variants of same disease with sim-
ilar outcomes [4,18]. Our results together with report of
Amri et al [3] and Pelletier at al [11] suggest SBP to be
more severe variant with poor prognosis than CNNA.
Early diagnosis of SBP along with prompt initiation of
appropriate antibiotic therapy can be helpful in overall
patient's survival.
Conclusion
In conclusion ascitic fluid infection is a serious and life
threatening complication of liver cirrhosis. SBP is associ-
ated with a higher mortality than CNNA. Patients with
raised serum creatinine levels and positive blood cultures
have poor prognosis, and they should be treated with
greater vigilance. In the new era advanced culture meth-
ods with high and early yield can facilitate a prompt and
accurate initiation of antibiotic therapy.
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